Cathie Wood's $362 Million CRISPR Bet: Hidden Catalyst
Cathie Wood’s big bet on CRISPR Therapeutics signals more than faith in gene editing. This article digs into the unde...
Learn about retirement plans that might be better than a 401k. Enhance your retirement strategy with informed choices.
27,827 articlesCathie Wood’s big bet on CRISPR Therapeutics signals more than faith in gene editing. This article digs into the unde...
When a CFO sells a notable chunk of stock, investors want clarity. This article breaks down what CoreWeave's sold com...
Investors weigh Amazon's Zoox-related progress against UPS's strategic shifts while oil volatility stirs the market. ...
A big-name investment fund backed an IoT stock with a $20 million stake last quarter. Since then, the stock has tumbl...
Macy’s posts a stronger-than-expected Q4, lifting shares in a downbeat retail environment. The company leans into cre...
A high-profile clash over AI in music doubles as a money lesson. Discover practical ways to protect earnings, invest ...
Dell Technologies leads the pack in 2026 among AI server stocks, outpacing Hewlett Packard Enterprise and Super Micro...
This in-depth piece dives into Chile's bold tax reform plan and what it could mean for growth, investment, and global...
XRP rallied on whispers of regulatory clarity, but the price action is tempered by cautious charts. This deep dive ex...
A sharp 36% February drop put Lemonade in the spotlight. This guide breaks down what happened, how the AI-driven grow...
Dogecoin has sparked fresh headlines with notable price moves. Before you jump in, learn how to assess the momentum, ...
New leadership at CMLS faces a fractured MLS landscape as mortgage markets and digital portals reshape U.S. housing f...